Header

UZH-Logo

Maintenance Infos

Nintedanib as a novel treatment option in hereditary haemorrhagic telangiectasia


Kovacs-Sipos, Evelin; Holzmann, David; Scherer, Thomas; Soyka, Michael B (2017). Nintedanib as a novel treatment option in hereditary haemorrhagic telangiectasia. BMJ Case Reports:bcr2017-219393.

Statistics

Altmetrics

Downloads

0 downloads since deposited on 21 Sep 2017
0 downloads since 12 months

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Otorhinolaryngology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2017
Deposited On:21 Sep 2017 10:47
Last Modified:21 Sep 2017 10:50
Publisher:BMJ Publishing Group
ISSN:1757-790X
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1136/bcr-2017-219393
PubMed ID:28652319

Download